PubMed for Bookshelf ID: 4854614

Year	Number of Results
2005	1
2006	1
2007	1
2009	2
2011	1
2013	1
2015	1
2016	1
2018	1
2024	0

1

Efficacy and safety of phosphodiesterase 4 inhibitors in patients with asthma: A systematic review and meta-analysis.

Luo J, Yang L, Yang J, Yang D, Liu BC, Liu D, Liang BM, Liu CT. Luo J, et al. Respirology. 2018 May;23(5):467-477. doi: 10.1111/resp.13276. Epub 2018 Mar 4. Respirology. 2018. PMID: 29502338 Free article. Review.

2

Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.

Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VK, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI. Martinez FJ, et al. Am J Respir Crit Care Med. 2016 Sep 1;194(5):559-67. doi: 10.1164/rccm.201607-1349OC. Am J Respir Crit Care Med. 2016. PMID: 27585384 Clinical Trial.

3

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network. Chalasani N, et al. Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6. Gastroenterology. 2015. PMID: 25754159 Free PMC article.

4

Drugs for asthma and COPD.

[No authors listed] [No authors listed] Treat Guidel Med Lett. 2013 Aug;11(132):75-86; quiz following 86. Treat Guidel Med Lett. 2013. PMID: 23896773 No abstract available.

5

Roflumilast (Daliresp) for COPD.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2011 Jul 25;53(1369):59-60. Med Lett Drugs Ther. 2011. PMID: 21778965 No abstract available.

6

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF; M2-127 and M2-128 study groups. Fabbri LM, et al. Lancet. 2009 Aug 29;374(9691):695-703. doi: 10.1016/S0140-6736(09)61252-6. Lancet. 2009. PMID: 19716961 Clinical Trial.

7

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups. Calverley PM, et al. Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1. Lancet. 2009. PMID: 19716960 Clinical Trial.

8

Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.

Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM. Calverley PM, et al. Am J Respir Crit Care Med. 2007 Jul 15;176(2):154-61. doi: 10.1164/rccm.200610-1563OC. Epub 2007 Apr 26. Am J Respir Crit Care Med. 2007. PMID: 17463412 Clinical Trial.

9

Efficacy and safety of roflumilast in the treatment of asthma.

Bateman ED, Izquierdo JL, Harnest U, Hofbauer P, Magyar P, Schmid-Wirlitsch C, Leichtl S, Bredenbröker D. Bateman ED, et al. Ann Allergy Asthma Immunol. 2006 May;96(5):679-86. doi: 10.1016/S1081-1206(10)61065-4. Ann Allergy Asthma Immunol. 2006. PMID: 16729780 Clinical Trial.

10

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.

Lipworth BJ. Lipworth BJ. Lancet. 2005 Jan 8-14;365(9454):167-75. doi: 10.1016/S0140-6736(05)17708-3. Lancet. 2005. PMID: 15639300 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year